Slider Test
2024 Year in Review: Therapeutics, Diagnostics, and Deep Learning Models Metastatic Breast Cancer Metastatic Breast Cancer Itovebi Receives FDA Approval for Advanced/Metastatic Breast Cancer Continued on next slide On...
Read MoreAuthor: Scott Smith
Year In Review – Endometrial Cancer
Oct 22, 2024
2024 Year in Review: Therapeutics, Diagnostics, and Deep Learning Models Endometrial Cancer Endometrial Cancer New FDA Approval Dostarlimab-gxly (Jemperli) On August 1, 2024, the FDA approved dostarlimab-gxly (Jemperli, GSK)...
Read More